Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Oct. 31, 2025	Oct. 31, 2024
Cash flows from operating activities:
Net loss	$ (18,212,000)	$ (8,365,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of fixed assets	398,000	456,000
Foreign exchange loss		(1,000)
Loss on disposal of property and equipment		111,000
Amortization of intangible assets	66,000	66,000
Amortization of right of use asset	414,000	418,000
Share-based compensation	5,191,000	551,000
Changes in operating assets and liabilities:
Accounts receivable	91,000	(989,000)
Contract assets	336,000	(68,000)
Inventory	(1,571,000)	(231,000)
Other assets	(322,000)	1,064,000
Accounts payable	871,000	(3,015,000)
Earnout payable	(100,000)	(100,000)
Accrued expenses	47,000	(359,000)
Right-of-use liabilities	(480,000)	(245,000)
Contract liabilities	135,000	(183,000)
Net cash used in operating activities	(13,136,000)	(10,890,000)
Cash flows from investing activities:
Purchases of property and equipment	(1,719,000)	(128,000)
Net cash used in investing activities	(1,719,000)	(128,000)
Cash flows from financing activities:
Proceeds from convertible notes	16,845,000
Proceeds from issuance of common stock - Capital Raise, net of issuance costs		2,451,000
Proceeds from issuance of common stock - At The Market offering, net of issuance costs	2,954,000	7,508,000
Net cash provided by financing activities	19,799,000	9,959,000
Net increase/(decrease) in cash, cash equivalents and restricted cash	4,944,000	(1,059,000)
Cash, cash equivalents and restricted cash, beginning of period	6,869,000	3,305,000
Cash, cash equivalents and restricted cash, end of period	11,813,000	2,246,000
Supplemental disclosure of noncash investing and financing activities:
Common stock issued related to bonus and earnout payments		630,000
Common stock issued related to conversion of convertible debt	5,775,000
Operating right of use asset obtained in exchange for operating lease liability	$ 1,276,000